Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis

YM Jeon, Y Kwon, S Lee, HJ Kim - Frontiers in Aging Neuroscience, 2023 - frontiersin.org
The endoplasmic reticulum (ER) is a major organelle involved in protein quality control and
cellular homeostasis. ER stress results from structural and functional dysfunction of the …

[HTML][HTML] Sigma-1 receptor and seizures

E Vavers, L Zvejniece, M Dambrova - Pharmacological Research, 2023 - Elsevier
Over the last decade, sigma-1 receptor (Sig1R) has been recognized as a valid target for the
treatment of seizure disorders and seizure-related comorbidities. Clinical trials with Sig1R …

Lonp1 and Sig-1R contribute to the counteraction of ursolic acid against ochratoxin A-induced mitochondrial apoptosis

Q Zhang, W Chen, B Zhang, Y Zhang, Y **ao… - Food and Chemical …, 2023 - Elsevier
Ochratoxin A (OTA), a secondary fungal metabolite with nephrotoxicity, is widespread in
numerous kinds of feeds and foodstuffs. Ursolic acid (UA), a water-insoluble pentacyclic …

SigmaR1 shapes rough endoplasmic reticulum membrane sheets

EM Sawyer, LE Jensen, JB Meehl, KP Larsen… - Developmental Cell, 2024 - cell.com
Rough endoplasmic reticulum (ER) sheets are a fundamental domain of the ER and the
gateway into the secretory pathway. Although reticulon proteins stabilize high-curvature ER …

Sigma-1 receptor maintains ATAD3A as a monomer to inhibit mitochondrial fragmentation at the mitochondria-associated membrane in amyotrophic lateral sclerosis

S Watanabe, M Horiuchi, Y Murata, O Komine… - Neurobiology of …, 2023 - Elsevier
Organelle contact sites are multifunctional platforms for maintaining cellular homeostasis.
Alternations of the mitochondria-associated membranes (MAM), one of the organelle contact …

Sigma-1 receptor signaling: in search of new therapeutic alternatives for cardiovascular and renal diseases

FJ Munguia-Galaviz, AG Miranda-Diaz… - International journal of …, 2023 - mdpi.com
Cardiovascular and renal diseases are among the leading causes of death worldwide, and
regardless of current efforts, there is a demanding need for therapeutic alternatives to …

Targeting Sigma-1 receptor: A promising strategy in the treatment of Parkinson's disease

T Siddiqui, LK Bhatt - Neurochemical research, 2023 - Springer
Parkinson's disease is a neurodegenerative disease affecting mainly the elderly population.
It is characterized by the loss of dopaminergic neurons of the substantia nigra pars …

Chaperone-dependent mechanisms as a pharmacological target for neuroprotection

MV Voronin, EV Abramova, ER Verbovaya… - International Journal of …, 2023 - mdpi.com
Modern pharmacotherapy of neurodegenerative diseases is predominantly symptomatic
and does not allow vicious circles causing disease development to break. Protein misfolding …

Sigma-1 receptor: A potential target for the development of antidepressants

YM Wang, CY **a, HM Jia, J He, WW Lian… - Neurochemistry …, 2022 - Elsevier
Though a great many of studies on the development of antidepressants for the therapy of
major depression disorder (MDD) and the development of antidepressants have been …

Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels

H Ma, J Li, X Qiao, Y Zhang, X Hou, H Chang… - Acta Pharmacologica …, 2024 - nature.com
Abstract Sigma-1 receptor (S1R) is a unique multi-tasking chaperone protein in the
endoplasmic reticulum. Since S1R agonists exhibit potent antidepressant-like activity, S1R …